NovaQuest Private Equity (NovaQuest) has made a strategic growth equity investment in Pro-ficiency, a provider of tech-enabled training and compliance solutions for clinical trial investigators and site staff

Based in Durham, NC, Pro-ficiency provides innovative, virtual simulation training and HR compliance solutions for clinical trials, supported by original content creation and analytics services. Leading pharmaceutical companies engage Pro-ficiency to deploy customised, study-specific training solutions that improve learning retention and strengthen compliance among investigators and site staff. The company’s platform also provides sponsors and CROs with real-time analytics that help to predict and avoid study errors and protocol violations, ultimately reducing the time, cost, and failure points of clinical trials. This integrated suite of services provides a compelling value proposition to its pharmaceutical customers.

“Pro-ficiency is excited to partner with NovaQuest, a firm with unparalleled global pharma and life sciences relationships and a proven track record of successfully supporting market-leading businesses in their next phase of growth,” says David Hadden, Co-Founder of Pro-ficiency. “With NovaQuest’s growth equity investment, Pro-ficiency is well-funded to continue changing the paradigm of clinical trial training.”

“Our customers are developing innovative products that require rigorous compliance across increasingly complex and global trials,” says JoAnne Schaberick, Co-Founder of Pro-ficiency. “NovaQuest’s expertise in life sciences and clinical trials will be invaluable as we continue to expand our team and offering to consistently surpass expectations and meet the needs of our valued customers.”

Read more/Source: Private Equity Wire